NO20004638D0 - Hypnotisk <beta>-karbolinderivater, fremgangsmÕte til deres fremstilling og deres anvendelse som legemiddelprodukt - Google Patents

Hypnotisk <beta>-karbolinderivater, fremgangsmÕte til deres fremstilling og deres anvendelse som legemiddelprodukt

Info

Publication number: NO20004638D0
Authority: NO; Norway
Prior art keywords: hypnotic; beta; preparation; drug product; carboline derivatives
Prior art date: 1998-03-17

Application number

NO20004638A

Other languages

English (en)

Other versions

NO317296B1 (no

NO20004638L (no

Inventor

Jean Bernard Fourtillan

Marianne Fourtillan

Jean-Claude Jacquesy

Marie-Paule Jouannetaud

Bruno Violeau

Omar Karam

Original Assignee

Cemaf

Besins Iscovesco Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-17

Filing date

2000-09-15

Publication date

2000-09-15

1998-03-17 Priority claimed from US09/042,990 external-priority patent/US6048868A/en

2000-09-15 Application filed by Cemaf, Besins Iscovesco Lab filed Critical Cemaf

2000-09-15 Publication of NO20004638D0 publication Critical patent/NO20004638D0/no

2000-11-16 Publication of NO20004638L publication Critical patent/NO20004638L/no

2004-10-04 Publication of NO317296B1 publication Critical patent/NO317296B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

NO20004638A 1998-03-17 2000-09-15 Hypnotisk <beta>- karbolinderivater, fremgangsmater til deres fremstilling og deres anvendelse som legemiddelprodukt NO317296B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/042,990 US6048868A (en)	1994-09-14	1998-03-17	Melatonin-antagonist β-carboline derivatives and analogues thereof containing naphthalenic structure, process for their preparation and their use as medicinal products
PCT/IB1999/000494 WO1999047521A1 (en)	1998-03-17	1999-03-17	HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS

Publications (3)

Publication Number	Publication Date
NO20004638D0 true NO20004638D0 (no)	2000-09-15
NO20004638L NO20004638L (no)	2000-11-16
NO317296B1 NO317296B1 (no)	2004-10-04

Family

ID=21924862

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20004638A NO317296B1 (no)	1998-03-17	2000-09-15	Hypnotisk <beta>- karbolinderivater, fremgangsmater til deres fremstilling og deres anvendelse som legemiddelprodukt

Country Status (24)

Country	Link
EP (1)	EP1064284B1 (no)
JP (1)	JP4333036B2 (no)
CN (1)	CN1115342C (no)
AR (1)	AR018767A1 (no)
AT (1)	ATE215087T1 (no)
AU (1)	AU752364B2 (no)
BG (1)	BG63973B1 (no)
BR (1)	BR9908833A (no)
CA (1)	CA2324270A1 (no)
DE (1)	DE69901098T2 (no)
DK (1)	DK1064284T3 (no)
ES (1)	ES2174632T3 (no)
HU (1)	HUP0101234A3 (no)
IL (1)	IL138442A (no)
IS (1)	IS2199B (no)
NO (1)	NO317296B1 (no)
NZ (1)	NZ506913A (no)
PL (1)	PL193450B1 (no)
PT (1)	PT1064284E (no)
RU (1)	RU2210571C2 (no)
SK (1)	SK284387B6 (no)
TR (1)	TR200003596T2 (no)
UA (1)	UA71911C2 (no)
WO (1)	WO1999047521A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2824829B1 (fr) *	2001-05-16	2005-06-03	Macef	Nouveaux derives de dihydroimidazo [5,1-a]-beta-carboline, leur procede de preparation et leur application a titre de medicament
FR2904973A1 (fr) *	2006-08-18	2008-02-22	Fourtillan Snc	Derives de 1-methylidene-pyrido[3,4-b]indole et leur utilisation en therapeutique.
FR2916200A1 (fr) *	2007-05-18	2008-11-21	Fourtillan Snc	Nouveaux derives des 1,2,3,4,6,7,12,12a-octahydro pyrazino[1',2':1,6]pyrido[3,4-b]indoles, leur preparation et leur utilisation en therapeutique
EP2476680B1 (en)	2008-01-11	2014-08-27	Albany Molecular Research, Inc.	(1-Azinone)-Substituted Pyridoindoles
WO2011003021A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003007A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
JP2012532144A (ja)	2009-07-01	2012-12-13	アルバニーモレキュラーリサーチ，インコーポレイテッド	アジノン置換アゼピノ［ｂ］インドールおよびピリド−ピロロ−アゼピンｍｃｈ−１拮抗薬、ならびにその作製方法および使用
US8618299B2 (en)	2009-07-01	2013-12-31	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
WO2012088038A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
WO2012088124A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
FI130627B (en) *	2021-03-31	2023-12-18	Equinorm Ltd	Novel heterocyclic compounds and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5283343A (en) *	1987-08-17	1994-02-01	Whitby Research, Inc.	2-aryl substituted N-acetyltryptamines and process of preparing such
HU207070B (en) *	1990-10-31	1993-03-01	Richter Gedeon Vegyeszet	Process for producing 1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,712,12balpha-octahydroindolo(2,3-a) quinolizine
RU2067980C1 (ru) *	1992-06-30	1996-10-20	Глэксо Груп Лимитед	Производные лактама и фармацевтическая композиция, являющаяся антагонистом 5-окситраптамина /5-нт/ на 5- нт3 -рецепторах или их физиологически приемлемые соли и соловаты
RU2068847C1 (ru) *	1994-05-18	1996-11-10	Всероссийский научный центр по безопасности биологически активных веществ	ПРОИЗВОДНЫЕ 3,4-ДИГИДРО- ИЛИ 1,2,3,4-ТЕТРАГИДРО- β -КАРБОЛИНОВ ИЛИ ИХ СОЛИ С ОРГАНИЧЕСКИМИ ИЛИ НЕОРГАНИЧЕСКИМИ КИСЛОТАМИ, ПРОЯВЛЯЮЩИЕ АНТИМИКРОБНУЮ АКТИВНОСТЬ
FR2724384B1 (fr) *	1994-09-14	1999-04-16	Cemaf	Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament

1999
- 1999-03-17 IL IL138442A patent/IL138442A/en not_active IP Right Cessation
- 1999-03-17 BR BR9908833-9A patent/BR9908833A/pt not_active Application Discontinuation
- 1999-03-17 AT AT99939844T patent/ATE215087T1/de not_active IP Right Cessation
- 1999-03-17 NZ NZ506913A patent/NZ506913A/en unknown
- 1999-03-17 RU RU2000126288/04A patent/RU2210571C2/ru not_active IP Right Cessation
- 1999-03-17 UA UA2000105839A patent/UA71911C2/uk unknown
- 1999-03-17 ES ES99939844T patent/ES2174632T3/es not_active Expired - Lifetime
- 1999-03-17 AR ARP990101166A patent/AR018767A1/es active IP Right Grant
- 1999-03-17 HU HU0101234A patent/HUP0101234A3/hu unknown
- 1999-03-17 DE DE69901098T patent/DE69901098T2/de not_active Expired - Lifetime
- 1999-03-17 DK DK99939844T patent/DK1064284T3/da active
- 1999-03-17 JP JP2000536716A patent/JP4333036B2/ja not_active Expired - Fee Related
- 1999-03-17 CA CA002324270A patent/CA2324270A1/en not_active Abandoned
- 1999-03-17 AU AU32707/99A patent/AU752364B2/en not_active Ceased
- 1999-03-17 SK SK1385-2000A patent/SK284387B6/sk not_active IP Right Cessation
- 1999-03-17 TR TR2000/03596T patent/TR200003596T2/xx unknown
- 1999-03-17 PT PT99939844T patent/PT1064284E/pt unknown
- 1999-03-17 CN CN99805687A patent/CN1115342C/zh not_active Expired - Fee Related
- 1999-03-17 PL PL99342929A patent/PL193450B1/pl not_active IP Right Cessation
- 1999-03-17 EP EP99939844A patent/EP1064284B1/en not_active Expired - Lifetime
- 1999-03-17 WO PCT/IB1999/000494 patent/WO1999047521A1/en not_active Ceased
2000
- 2000-09-12 IS IS5627A patent/IS2199B/is unknown
- 2000-09-14 BG BG104768A patent/BG63973B1/bg unknown
- 2000-09-15 NO NO20004638A patent/NO317296B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
RU2210571C2 (ru)	2003-08-20
PT1064284E (pt)	2002-09-30
HUP0101234A3 (en)	2002-12-28
IL138442A (en)	2006-12-10
DE69901098D1 (de)	2002-05-02
AU3270799A (en)	1999-10-11
PL342929A1 (en)	2001-07-16
IL138442A0 (en)	2001-10-31
HUP0101234A2 (hu)	2001-12-28
ES2174632T3 (es)	2002-11-01
PL193450B1 (pl)	2007-02-28
EP1064284B1 (en)	2002-03-27
IS5627A (is)	2000-09-12
DE69901098T2 (de)	2002-11-21
CN1115342C (zh)	2003-07-23
CN1299361A (zh)	2001-06-13
BG104768A (en)	2001-05-31
ATE215087T1 (de)	2002-04-15
EP1064284A1 (en)	2001-01-03
WO1999047521A1 (en)	1999-09-23
SK13852000A3 (sk)	2001-09-11
SK284387B6 (sk)	2005-02-04
CA2324270A1 (en)	1999-09-23
TR200003596T2 (tr)	2001-04-20
UA71911C2 (en)	2005-01-17
JP2002506867A (ja)	2002-03-05
AR018767A1 (es)	2001-12-12
JP4333036B2 (ja)	2009-09-16
NO317296B1 (no)	2004-10-04
BG63973B1 (bg)	2003-08-29
NZ506913A (en)	2003-07-25
BR9908833A (pt)	2000-11-21
NO20004638L (no)	2000-11-16
AU752364B2 (en)	2002-09-19
DK1064284T3 (da)	2002-07-22
IS2199B (is)	2007-02-15

Publication	Publication Date	Title
DK1218341T3 (da)	2005-12-12	Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20025879D0 (no)	2002-12-06	Acylfenylureaderivater, fremgangsmåte for fremstilling derav og deres anvendelse som et legemiddel
EE200100431A (et)	2002-12-16	16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
NO20021689L (no)	2002-05-30	5-leddede heterocykliske derivater, fremstilling derav og anvendelse som medikamenter
NO20032733L (no)	2003-08-14	Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
DK1006110T3 (da)	2004-04-26	Derivater af acylpiperazinylpyrimidiner, fremstilling deraf og anvendelse som lægemidler
NO20006029L (no)	2001-01-26	Pyrazolinderivater, deres fremstilling og anvendelse som legemidler
NO20021719D0 (no)	2002-04-11	6-posisjon substituerte indoliner, fremstilling og anvendelse derav som medikament
NO20032438L (no)	2003-07-09	Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene
DK1202965T3 (da)	2005-02-14	Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
NO20011503D0 (no)	2001-03-23	Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler
NO994620D0 (no)	1999-09-23	Nye 2-(iminometyl)amino-fenyl-derivater, fremstilling, anvendelse som medisiner og farmasöytiske blandinger inneholdende disse
NO20012272D0 (no)	2001-05-09	Nye erythromycinderivater, fremstillingsmetode og anvendelse som medisiner
DK1095020T3 (da)	2006-01-16	2-Aminopyridinderivater, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem
DK1230230T3 (da)	2003-12-15	Derivater af indeno-dihydrothiazol, fremstilling deraf og anvendelse som anorektiske lægemidler
NO20015659L (no)	2002-01-18	Purinderivater, fremstillingsmetode og farmasöytiske preparater inneholdende disse
NO20004638D0 (no)	2000-09-15	Hypnotisk <beta>-karbolinderivater, fremgangsmÕte til deres fremstilling og deres anvendelse som legemiddelprodukt
NO20016404L (no)	2002-03-01	Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20010219L (no)	2001-03-15	Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
DK1053224T3 (da)	2002-12-23	Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
EE200100499A (et)	2002-12-16	Uued morfoliini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE04437B1 (et)	2005-02-15	(1-fenatsüül-3-fenüül-3-piperidinüületüül)piperidiini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
NO992859L (no)	1999-06-11	Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter
NO20020308D0 (no)	2002-01-21	Fremgangsmåte for fremstilling av epothiolon B og derivater, såvel som mellomprodukter for fremgangsmåten
NO20042022L (no)	2004-05-14	Fast legemiddelformulering som inneholder pipiperazinurea-derivat og fremgangsmate for fremstilling av formuleringen

Legal Events

Date	Code	Title	Description
2011-10-24	MM1K	Lapsed by not paying the annual fees